A new drug derived from marijuana has led to a landmark change in the US government's stance on cannabis.

After being greenlit as the first federally approved cannabis-based medication at the end of June, the drug has triggered the nation's top drug enforcer to change how it regulates marijuana.

It's the first time in 46 years that the agency has shifted its stance on a marijuana compound.

The drug, Epidiolex, is designed to treat two rare forms of childhood epilepsy using cannabidiol, or CBD, the compound in marijuana not responsible for a high. 

Click here to read the complete article

Erin Brodwin ~ BusinessInsider.com

Recent News Articles

Monday October 21

Key Northeastern governors join forces to chart a path to legalizing marijuana - Cannabis News

in Top Stories

by Bruce Kennedy - Editor in Chief

The governors of Pennsylvania, New Jersey, Connecticut, and New York met Thursday for a summit…

963 hits

Monday October 21

UConn Launches Hemp Testing Lab in Response to Industry Need - Cannabis News

in Science

by Bruce Kennedy - Editor in Chief

In response to a rapidly expanding commercial hemp industry driven by interest in products with…

1017 hits

Monday October 21

Slow rollout in marijuana sales costs Maine revenue and jobs - Cannabis News

in Finance

by Bruce Kennedy - Editor in Chief

Three years after legalizing adult-use marijuana, the state’s still waiting for retail shops. Consultants say…

977 hits

Monday October 21

Chesapeake Bay scientists studying environmental, economic uses for hemp - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

A Gold Rush mentality has erupted across Chesapeake Bay states as the lacy fan-shaped leaves…

1437 hits

Tuesday October 22

Michael J. Fox Parkinson’s Foundation Urges Congress To Pass Three Marijuana Research Bills - Cannabis…

in Activism

by Bruce Kennedy - Editor in Chief

A leading advocacy group that’s dedicated to finding treatment options for Parkinson’s disease is backing…

834 hits